Bio-Rad LaboratoriesBIO
NYSE · USA · Segment 6 of 8 in the Medicine, pharma & life science value chain: Diagnostics
American manufacturer of products for clinical diagnostics and life science research — including blood typing and droplet digital PCR.
Diagnostics: Tests, imaging and assays that support clinical decision-making.
Key metrics
Market cap
$8B
Price
$296.77
Today
−0.2%
Return YTD
−1.9%
Return 1Y
+17.5%
P/E
47.4
P/S
3.1
P/B
1.2
Data as of 2026-07-10 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Clinical diagnostics
- Life science research equipment
- Digital PCR
Competitors
- Thermo Fisher
- Danaher
- Qiagen
Risks
- Cyclical research demand
- Value tied to Sartorius stake
Same segment: Diagnostics
See where Bio-Rad Laboratories sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →